How does PXS's PE Ratio compare to its peers?

PXS is expensive based on its Price-To-Earnings Ratio (96.8x) compared to the peer average (22.7x).

How does PXS's PE Ratio compare vs other companies in the European Healthcare Industry?

PXS is expensive based on its Price-To-Earnings Ratio (96.8x) compared to the European Healthcare industry average (19.8x).

What is PXS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PXS is expensive based on its Price-To-Earnings Ratio (96.8x) compared to the estimated Fair Price-To-Earnings Ratio (41.5x).

What is the Fair Price of PXS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

PXS (€0.28) is trading above our estimate of [[fair value]] (€0.27)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

PXS Stock Overview

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. More details

PXS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	1/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings are forecast to grow 36.99% per year

Risk Analysis

Volatile share price over the past 3 months compared to the German market

Large one-off items impacting financial results

Has a high level of debt

Significant insider selling over the past 3 months

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

Paragon Care Limited Competitors

Medios

XTRA:ILM1

€307.7m

M1 Kliniken

XTRA:M12

€283.0m

RHÖN-KLINIKUM

XTRA:RHK

€984.0m

Eckert & Ziegler

XTRA:EUZ

€1.0b

Price History & Performance

Summary of share price highs, lows and changes for Paragon Care
Historical stock prices
Current Share Price	AU$0.28
52 Week High	AU$0.30
52 Week Low	AU$0.22
Beta	0
1 Month Change	0%
3 Month Change	10.08%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	29.09%

Recent updates

Shareholder Returns

	PXS	DE Healthcare	DE Market
7D	1.4%	3.0%	3.0%
1Y	n/a	31.5%	13.2%

Return vs Industry: Insufficient data to determine how PXS performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how PXS performed against the German Market.

Price Volatility

Is PXS's price volatile compared to industry and market?
PXS volatility
PXS Average Weekly Movement	6.9%
Healthcare Industry Average Movement	4.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: PXS's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: PXS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
n/a	550	David Collins	www.paragoncare.com.au

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. It operates through two segments: ParagonCare and CH2. The company offers its for aesthetics, controlle, critical care, diagnostic and scientific, eye care, medical products and consumables, neonatal, orthopaedics service, surgical, technology & connectivity, urology, and veterinary products.

Paragon Care Limited Fundamentals Summary

How do Paragon Care's earnings and revenue compare to its market cap?
PXS fundamental statistics
Market cap	€488.22m
Earnings (TTM)	€5.04m
Revenue (TTM)	€1.79b

96.8x

P/E Ratio

0.3x

P/S Ratio

Is PXS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PXS income statement (TTM)
Revenue	AU$2.97b
Cost of Revenue	AU$2.79b
Gross Profit	AU$176.07m
Other Expenses	AU$167.69m
Earnings	AU$8.38m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.0051
Gross Margin	5.93%
Net Profit Margin	0.28%
Debt/Equity Ratio	62.7%

How did PXS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/21 15:50
End of Day Share Price	2025/01/21 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Paragon Care Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
Thomas Godfrey	Ord Minnett Limited